Synthesis of curcumin and ethylcurcumin bioconjugates as potential antitumor agents

Medicinal Chemistry Research

Volumn 21, Issue 6, 2012, Pages 874-890

  Al Wabli, Reem I ^a   AboulWafa, Omaima M ^b   Youssef, Khairia M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b FUTURE UNIVERSITY IN EGYPT   (Egypt)

Author keywords

Antitumor activity; Curcumin and ethylcurcumin bioconjugates; Curcumin derivatives

Indexed keywords

1,7 BIS(4 (2 CHLOROETHYL)AMINO PROPIONYLOXY) 3 (METHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (2 CHLOROETHYL)AMINOACETYLOXY) 3 (ETHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (2 DIETHYLAMINOETHYL)AMINO ACETYLOXYY) 3 (METHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (2 DIETHYLAMINOETHYL)AMINOACETYLOXY) 3 (ETHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (2 DIMETHYLAMINOETHYL)AMINOACETYLOXY)3 (ETHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (4 SULFANILAMIDO)ACETYLOXY) 3 (METHOXY PHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (4 SULFANILAMIDO)ACYLOXY) 3 (ETHOXYPHENYL BIS(4 (4 SULFANILAMIDO)ACYLOXY) 3 (ETHOXYPHENYL, 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (4 SULFANILAMIDO)ACYLOXY) 3 (ETHOXYPHENYL) 1,6 HEPTA DIENE 3 5 DIONE; 1,7 BIS(4 (4 SULFANILAMIDO)ACYLOXY) 3 (METHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (5 METHYLTHIA DIAZOL 2 YL)AMINOPROPIONYLOXY) 3 (METHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (5 METHYLTHIADIAZOL 2 YL)AMINOACETYLOXY) 3 (METHOXY PHENYL) 1,6-HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (6 METHOXYBENZOTHIAZOL 2 YL)AMINOACETYLOXY) 3 (ETHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (BIS(2 CHLOROETHYL) AMINO ACETYLOXY) 3 (METHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 (BIS(2 CHLOROETHYL)AMINOACETYLOXY) 3 (ETHOXY-PHENYL) 1,6 HEPTADIENE 3,5 DIONE; 1,7 BIS(4 ALKYL(CYCLOALKYL OR HETEROARYL)AMINOACYLOXY) 3 (METHOXYPHENYL) 1,6 HEPTA DIENE 3,5 DIONE; 3 ALKOXY 4 CHLOROACYLOXYBENZALDEHYDE; 5 METHYLTHIADIAZOLE; 6 METHOXY BENZOTHIAZOLE; ANTINEOPLASTIC AGENT; CURCUMIN; DI O CHLOROACETYLCURCUMIN; DI O CHLOROPROPIONYLCURCUMIN; DIETHYLAMINOETHYL; DOXORUBICIN; ETHYLCURCUMIN; HETEROARYL)AMINOACYLOXY) 3 (ETHOXYPHENYL) 1,6 HEPTADIENE 3,5 DIONE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CYTOTOXICITY; DRUG CONJUGATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PHYSICAL CHEMISTRY;

EID: 84861841861     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9587-3     Document Type: Article

References (37)

1. Al-Omar MA, Youssef KM, El-Sherbeny MA, Awadalla AA, El-Subbagh HI (2005) Synthesis and in vitro antioxidant activity of some new fused pyridine analogs. Arch Pharm Pharm Chem Life Sci 338:181-189 (Pubitemid 40733783)
2. Anderson AM, Mitchell MS, Mohan RS (2000) Isolation of curcumin from turmeric. J Chem Educ 77:359-360
3. Burke PJ, Koch TH (2004) Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells. J Med Chem 47:1193-1206 (Pubitemid 38229121)
4. Crabbe P, Maldonado LA, Sanchez I (1971) Synthesis of new heterocyclic derivatives of estradiol. Tetrahedron 27:711-725
5. Foye WO, Sengupta SK (1995) Cancer chemotherapy. In: Foye WO, Lemke TL, Williams DA (eds) Principles of medicinal chemistry, chap 37. Lippincott Williams and Wilkins, Philadelphia, p 839
6. Huang MT, Smart RC, Wong CQ, Conney AH (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on 13-acetate. Cancer Res 48:5941-5946
7. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR, Conney AH (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54:5841-5847 (Pubitemid 24375217)
8. Huang MT, Newmark HL, Frenkel K (1997) Inhibitory effects of curcumin on tumorigenesis in mice. Cancer Res 27:26-34 (Pubitemid 28222116)
9. Ishida J, Ohtsu H, Tachibana Y, Nakanishi Y, Bastow KF, Nagai M, Wang HK, Itokawa H, Lee KH (2002) Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents. Biorg Med Chem 10:3481-3487
10. Jovanovic SV, Steenken S, Boone CW, Simic G (1999) How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc 121:9677-9681
11. Jovanovic SV, Boone CW, Steenken S, Trinoga M, Kaskey RB (2001) How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc 123:3064-3068 (Pubitemid 32879574)
12. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC (1994) Chemopreventive drug development: perspectives and progress. Cancer Epidemiol Biomarkers Prev 3:85-98 (Pubitemid 24172528)
13. Khopde SM, Priyadarsini KI, Venkatesan P, Rao MNA (1999) Free radical scavenging ability and antioxidant efficiency of curcumin and its substituted analogue. Biophys Chem 80:85-91
14. Kiso Y, Suzuki Y, Suzuki N, Watanabe N (1983) Antihepatotoxic principles of curcuma longa rhizomes. Planta Med 49:185-187 (Pubitemid 14220766)
15. Kumar S, Narian U, Tripathi S, Misra K (2001) Syntheses of curcumin bioconjugates and study of their antibacterial activities against b-lactamase-producing microorganisms. Bioconjugate Chem 12:464-469 (Pubitemid 32696218)
16. Kunchandy E, Rao MNA (1990) Oxygen radical scavenging activity of curcumin. Int J Pharm 58:237-240 (Pubitemid 20079739)
17. Lin LI, Ke YF, Ko YC, Lin JK (1998) Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppress matrix metalloproteinase-9 secretion. Oncology 55:349-353
18. Lock RB, Stribinskiene L (1996) Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 56(17):4006-4012 (Pubitemid 26284752)
19. Luo QL, Li JY, Liu ZY, Chen LL, Li J, Qian Z, Shen Q, Li Y, Lushington GH, Ye QZ, Nan FJ (2003) Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. J Med Chem 46:2631
20. Masuda T, Maekawa T, Hidaka K, Bando H, Takeda Y, Yamaguchi H (2001) Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate. J Agric Food Chem 49(5):2539-2547 (Pubitemid 32843288)
21. Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pomier Y (1995) Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49:1165-1170
22. Mehta K, Pantazis P, McQueen T, Aggarwal BB (1997) Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8:470-481 (Pubitemid 27310917)
23. Mohri K, Watanabe Y, Yoshida Y, Sato M, Isobe K, Sugimoto N, Tsuda Y (2003) Synthesis of glycosylcurcuminoids. Chem Pharm Bull 51:1268-1272 (Pubitemid 41685583)
24. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK (1982) Antiinflammatory and irritant activities of curcumin analogues in rats. Agents Actions 12:508-515 (Pubitemid 13218984)
25. Nurfina AN, Reksohadiprodjo MS, Timmerman H, Jenie UA, Sugiyanto D, Van Der Goot H (1997) Synthesis of some symmetrical curcumin derivatives and their antiinflammatory activity. Eur J Med Chem 32:321-328 (Pubitemid 27220263)
26. Rajakrishnan V, Viswanathan P, Rajasekharan KN, Menon VP (1999) Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage. Phytother Res 13:571-574 (Pubitemid 29520932)
27. Rao TS, Basu N, Siddiqui HH (1982) Antiinflammatory activity of curcumin analogues. Ind J Med Res 75:574-578
28. Roninson IB, Broude EV, Chang BD (2001) Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Update 4:303-313 (Pubitemid 34456384)
29. Roughley PJ, Whiting DA (1973) Experiments in the biosynthesis of curcumin. J Chem Soc Perkin Trans I 20:2379-2388
30. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R (1995) Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79-83
31. Sharma OP (1976) Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25:1811-1812
32. Snyder RD, Arnone MR (2002) Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutat Res 503:21-35 (Pubitemid 34614560)
33. Soudamini KK, Kuttan R (1989) Inhibition of chemical carcinogenesis by curcumin. J Ethnopharm 27:227-233 (Pubitemid 20018077)
34. Sreejayan RMN, Rao MNA (1994) Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46:1013-1016
35. Srimal RC, Dhawan BN (1973) Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25(6):447-452
36. Toda S, Miyase T, Arichi H, Tanizawa H, Takino Y (1985) Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem Pharmaceut Bull 33(4):1725-1728 (Pubitemid 15046105)
37. Youssef KM, El-Sherbeny MA, El-Shafie FS, Farag HA, Al-Deeb OA, Awadalla SAA (2004) Synthesis of curcumin analogues as potential antioxidant, cancer chemopreventive agents. Arch Pharm Pharm Med Chem 337:42-54 (Pubitemid 38222249)